Clearmind Medicine Inc. (CMND)

NASDAQ: CMND · IEX Real-Time Price · USD
3.64
-0.06 (-1.62%)
Dec 6, 2022 3:05 PM EST - Market open
-1.62%
Market Cap 9.15M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 1.32M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 17,606
Open 3.5
Previous Close 3.7
Day's Range 3.42 - 3.85
52-Week Range 3 - 6.1
Beta 1.35
Analysts n/a
Price Target n/a
Earnings Date n/a

About CMND

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada. [Read more]

Industry Biotechnology
Founded 2017
Country Canada
Stock Exchange NASDAQ
Ticker Symbol CMND
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial

VANCOUVER, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (CSE: CMND), (FSE: CWY) (“Clearmind” or the "Company"), a biotech company focused on discovery and development of nov...

1 week ago - GlobeNewsWire

Aegis Capital Corp. Acted as Sole Bookrunner on a $7.5 Million Underwritten Public Offering & Uplisting for Clearmind...

NEW YORK, NY / ACCESSWIRE / November 17, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $7.5 Million Underwritten Public Offering & Uplisting for Clearmind Medicine Inc. (NASDAQ:CMND). About C...

2 weeks ago - Accesswire

Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market

VANCOUVER, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq and CSE: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a biotech company focused on discovery and development of novel p...

2 weeks ago - GlobeNewsWire